Chronic kidney disease (CKD) poses a significant and escalating health burden in India, marked by high prevalence and incidence rates. The silent nature of CKD often leads to late diagnosis, as patients frequently present with substantial kidney impairment. Artificial intelligence (AI) presents a transformative opportunity by leveraging its ability to analyze complex patient data and identify individuals at high risk of developing or progressing in CKD, even before clinical symptoms manifest or significant damage occurs. AI algorithms can detect subtle trends across various health indicators, such as declining kidney function markers, uncontrolled diabetes, or hypertension, signaling a higher likelihood of rapid disease progression. This predictive capability allows for timely and targeted interventions, including enhanced monitoring, optimized management of chronic conditions, and earlier consultation with nephrologists, ultimately aiming to prevent severe outcomes. While AI serves as a powerful supporting tool for healthcare professionals, it is essential to acknowledge its limitations and the need for rigorous validation of models within diverse populations, such as India, ensuring that clinical judgment remains paramount in patient care. The true potential of AI in nephrology lies in its capacity to facilitate a paradigm shift from reactive treatment to proactive prevention, heralding a new era of early intervention and improved renal health outcomes.

Chronic kidney disease (CKD) poses a significant and escalating health burden in India, marked by high prevalence and incidence rates. The silent nature of CKD often leads to late diagnosis, as patients frequently present with substantial kidney impairment. Artificial intelligence (AI) presents a transformative opportunity by leveraging its ability to analyze complex patient data and identify individuals at high risk of developing or progressing in CKD, even before clinical symptoms manifest or significant damage occurs. AI algorithms can detect subtle trends across various health indicators, such as declining kidney function markers, uncontrolled diabetes, or hypertension, signaling a higher likelihood of rapid disease progression. This predictive capability allows for timely and targeted interventions, including enhanced monitoring, optimized management of chronic conditions, and earlier consultation with nephrologists, ultimately aiming to prevent severe outcomes. While AI serves as a powerful supporting tool for healthcare professionals, it is essential to acknowledge its limitations and the need for rigorous validation of models within diverse populations, such as India, ensuring that clinical judgment remains paramount in patient care. The true potential of AI in nephrology lies in its capacity to facilitate a paradigm shift from reactive treatment to proactive prevention, heralding a new era of early intervention and improved renal health outcomes.

Chronic kidney disease (CKD) poses a significant and escalating health burden in India, marked by high prevalence and incidence rates. The silent nature of CKD often leads to late diagnosis, as patients frequently present with substantial kidney impairment. Artificial intelligence (AI) presents a transformative opportunity by leveraging its ability to analyze complex patient data and identify individuals at high risk of developing or progressing in CKD, even before clinical symptoms manifest or significant damage occurs. AI algorithms can detect subtle trends across various health indicators, such as declining kidney function markers, uncontrolled diabetes, or hypertension, signaling a higher likelihood of rapid disease progression. This predictive capability allows for timely and targeted interventions, including enhanced monitoring, optimized management of chronic conditions, and earlier consultation with nephrologists, ultimately aiming to prevent severe outcomes. While AI serves as a powerful supporting tool for healthcare professionals, it is essential to acknowledge its limitations and the need for rigorous validation of models within diverse populations, such as India, ensuring that clinical judgment remains paramount in patient care. The true potential of AI in nephrology lies in its capacity to facilitate a paradigm shift from reactive treatment to proactive prevention, heralding a new era of early intervention and improved renal health outcomes.

There is a significant inequality in the burden of chronic kidney disease (CKD) in India. In an analysis presented in 2026 in the Indian Journal of Medical Research, based on data from the Global Burden of Disease 2023, it was found that in 2023, the prevalence of CKD in Indian States was 10,452–12,539 per 100,000 population and incidence was 226.4–316.4 per 100,000. These numbers point to a growing burden of kidney disease and to the urgent need to identify patients at risk before the disease progresses.

A particular problem with CKD is its silent course. Patients often have no symptoms and reach a clinic only once kidney function is already substantially impaired. This is where artificial intelligence (AI) can help by identifying patients at high risk of developing CKD before that damage occurs.

From CKD detection to prediction of its progression

Today, we assess kidney health through measures such as serum creatinine, eGFR, albuminuria, blood pressure, glycemia, and patient history. These measurements remain essential. But kidney disease is dynamic; a one-time snapshot cannot tell us how fast it is progressing.

AI can analyse multiple parameters at once and, more importantly, identify trends across them. A gradual decline in eGFR, persistent proteinuria, poorly controlled diabetes or hypertension, and shifts in other lab values, taken together, can signal a faster-progressing disease course.

Machine learning models that analyse these parameters to estimate future CKD progression and renal failure risk are now under active development, and early research has shown promising accuracy in some kidney-disorder studies. That said, this is not about AI predicting the precise date of renal failure.

What it can do is identify a risk trend in patients whose clinical profile suggests a likelihood of progressive kidney damage if no timely intervention is undertaken.

How early warnings can transform kidney disease care

The primary benefit of such predictions is early intervention. If a patient is flagged as high-risk for progression, we can act sooner to intensify screening, tighten blood pressure and glucose control, review medications, address proteinuria, recommend lifestyle changes, and bring in a nephrologist earlier in the treatment process.

For instance, a diabetic patient may show relatively preserved kidney function on eGFR, yet also have rising urine albumin, poor glucose control, and a slow underlying decline in kidney function. An AI system can link these signals together and flag the patient’s risk to the physician — a pattern that might otherwise go unnoticed until function has dropped further.

This is especially relevant in the Indian context, where many CKD patients present only once the disease is already advanced.

Supporting tool, but not a replacement for a doctor

Appealing as this is, AI should not replace medical judgment. An algorithm finds patterns; a doctor weighs the full clinical picture, symptoms, history, examination, and context to decide on treatment.

There are also open questions about data quality and how well a model trained elsewhere generalises to a different population. Algorithms built on non-Indian datasets would need to be rigorously validated before use in Indian patients, an evidence gap that still needs to be closed.

The AI-generated risk score should not be seen as a diagnosis. It should be used only as a supporting factor in decision-making about the need for close follow-up and early intervention.

Proactive prevention of kidney problems in the future

AI’s real value in nephrology is not in predicting the date a patient will reach kidney failure; it is in flagging the early signals of a disease heading that way. Identify the patients at risk of rapid kidney function loss, and we can act before serious damage is done. Done right, AI could become a standard part of preventive kidney care in India within the next few years, helping shift the country’s CKD story from late diagnosis to early prevention. 

The author is a DM (AIIMS) and senior nephrologist at NephroPlus. 

 

The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK. 

TAGS